MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, LRMR had $52,194K increase in cash & cash equivalents over the period. -$113,292K in free cash flow.

Cash Flow Overview

Change in Cash
$52,194K
Free Cash flow
-$113,292K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Maturities of marketable securit...
    • Proceeds from issuance of common...
    • Accrued expenses
    • Others
Negative Cash Flow Breakdown
    • Purchases of marketable securiti...
    • Amortization of premium on marke...
    • Lease expense
    • Purchases of property and equipm...

Cash Flow
2025-12-31
Operating expenses
172,497
Other income, net
6,824
Net loss
-165,673
Stock-based compensation expense
7,004
Lease expense
-281
Depreciation expense
350
Amortization of premium on marketable securities
-1,698
Prepaid expenses and other current assets
-6,680
Accounts payable
2,792
Accrued expenses
37,552
Other assets
-73
Net cash used in operating activities
-113,201
Purchases of property and equipment
91
Purchases of marketable securities
83,600
Maturities of marketable securities
184,000
Net cash provided by (used in) investing activities
100,309
Proceeds from issuance of common stock, net of issuance costs
65,086
Net cash provided by financing activities
65,086
Net increase in cash, cash equivalents and restricted cash
52,194
Cash, cash equivalents and restricted cash at beginning of period
33,824
Cash, cash equivalents and restricted cash at end of period
86,018
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Maturities of marketablesecurities$184,000K Proceeds from issuance ofcommon stock, net of...$65,086K Net cash provided by(used in) investing...$100,309K Net cash provided byfinancing activities$65,086K Canceled cashflow$83,691K Net increase incash, cash...$52,194K Canceled cashflow$113,201K Purchases of marketablesecurities$83,600K Purchases of property andequipment$91K Accrued expenses$37,552K Stock-based compensationexpense$7,004K Prepaid expenses andother current assets-$6,680K Accounts payable$2,792K Depreciation expense$350K Other assets-$73K Net cash used inoperating activities-$113,201K Canceled cashflow$54,451K Other income, net$6,824K Net loss-$165,673K Canceled cashflow$6,824K Amortization of premium onmarketable securities-$1,698K Lease expense-$281K Operating expenses$172,497K

Larimar Therapeutics, Inc. (LRMR)

Larimar Therapeutics, Inc. (LRMR)